Skip to main content
. 2022 Dec 27;11(1):58. doi: 10.3390/vaccines11010058

Table 1.

Demographic and clinical characteristics of the cohort.

Total 36
Demographics
Age (median [IQR], Range) 49 [43.5, 55.25] (24–62)
Sex (Male/Female) 8/28
SARS-CoV-2 Prior Infection (Yes/No) 11/28
BNT162b2 Samples (1st dose/2nd Dose) 13/13
mRNA-1273 Samples (1st dose/2nd Dose) 7/7
AZD1222 Samples (1st dose/2nd Dose) 16/16
Time of bleed after 1st dose 21 days (BNT162b2 and mRNA-1273) 12 weeks (AZD1222)
Time of bleed after 2nd dose 15 weeks